Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Acta Oncologica (Stockholm, Sweden)|January 9, 2018
Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapyGeorge Papaxoinis, Konstantinos Kamposioras, Theodora Germetaki, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort StudyGeorge Papaxoinis, Konstantinos Kamposioras, Jamie M J Weaver, et al.
Neuroendocrinology|October 23, 2019
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine NeoplasmsKok Haw Jonathan Lim, Hussain Raja, Paolo D'Arienzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2014
Differential role of Th1 and Th2 cytokines in autotoxicity driven by CD19-specific second-generation chimeric antigen receptor T cells in a mouse modelEleanor J Cheadle, Victoria Sheard, Dominic G Rothwell, et al.
Cancers|December 11, 2022
T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC)Luca G Campana, Wasat Mansoor, James Hill, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2016
Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancerMarkus Moehler, Rolf Mahlberg, Volker Heinemann, et al.
BMC Cancer|October 12, 2016
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinomaDavid Propper, Keith Jones, D Alan Anthoney, et al.
Neuroendocrinology|February 1, 2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine CarcinomasMelissa Frizziero, Francesca Spada, Angela Lamarca, et al.
Oncotarget|March 31, 2018
PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumoursAngela Lamarca, Daisuke Nonaka, Wolfgang Breitwieser, et al.
Endocrine|July 27, 2022
Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameterKlaire Exarchou, Haiyi Hu, Nathan A Stephens, et al.
Pageof 7